Form 4: ClearPoint Neuro CFO D'Alessandro Reports Stock Transactions
SEC Form 4 Filing
ClearPoint Neuro's CFO, Danilo D'Alessandro, reports the acquisition and disposal of common stock and restricted stock units on March 6, 2025.
Summary
- On March 6, 2025, Danilo D'Alessandro, CFO of ClearPoint Neuro, Inc. (CLPT), reported transactions involving the company's stock.
- D'Alessandro acquired 18,765 shares of common stock through the settlement of restricted stock units.
- He also disposed of 9,529 shares to satisfy tax withholding obligations at a price of $13.19 per share.
- Following these transactions, D'Alessandro beneficially owns 60,677 shares of ClearPoint Neuro common stock.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions by a company executive. It doesn't inherently indicate positive or negative sentiment, but rather reflects standard compensation and ownership adjustments.
Key Dates
| Date | Description |
|---|---|
| 03/06/2025 | Date of stock transactions (acquisition and disposal) and settlement of restricted stock units. |
| 03/10/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.